Three years ago, Alnylam Pharmaceuticals partnered with Northeastern University to become the first Fellowship Program at a pre-commercial company. Since its inception, the Program has grown and continues to be an integral asset to all stakeholders. For the 2018-2020 recruitment cycle, the Fellowship Program proudly offers four 2-year positions in the following expertise areas: Medical Affairs, Medical Information, Value and Evidence Strategy/Health Economics and Outcomes Research (VESt/HEOR), and Regulatory Affairs. The first year, Fellows customize their experience with individualized elective rotations throughout various groups at Alnylam while remaining a vital member in their core expertise area. In the second year, Fellows focus on their primary function. Throughout the two years, Fellows also have responsibilities at Northeastern University, such as teaching PharmD students and participating in longitudinal research with faculty.
We are always looking for curious and driven candidates! If you would like to receive updates from us, click here to sign up.
Positions at Alnylam
Medical Affairs Fellow
Medical Information Fellow
Value and Evidence Strategy/Health Economics and Outcomes Research (VESt/HEOR) Fellow
Regulatory Affairs Fellow
Tetraphase Pharmaceuticals is excited to partner with Northeastern University and the School of Pharmacy to offer a two-year Medical Affairs fellowship program starting in July 2018. Tetraphase is a biopharmaceutical company developing an antibiotic pipeline with the goal of bringing these important medicines to patients with infections caused by drug-resistant bacteria. This is a dynamic time at the company and the first fellow will have the unique opportunity to be involved in multiple facets of the drug development process. The Medical Affairs Fellow will develop a broad understanding of the inner workings of a Medical Affairs group through participation in all functional aspects of the department and ultimately have the flexibility to select and lead cross-functional projects.
As we prepare to commercialize our first product, we are looking for a driven individual who is eager to launch their career in the biopharmaceutical industry by gaining valuable experience in a dynamic, growing company. For more information please email email@example.com.
Bioverativ is proud to partner with Northeastern University to offer two fellowship programs through the 2018-2020 recruitment cycle in: Medical Affairs, and Regulatory Affairs. The first year, Fellows customize their experience with individualized elective rotations throughout various groups at Bioverativ, while remaining a vital member in their core expertise area. In the second year, Fellows focus on their primary function. Throughout the two years, Fellows also have responsibilities at Northeastern University, such as teaching PharmD students and participating in longitudinal research with faculty.
Global Medical Fellowship
The core responsibility of Medical at Bioverativ is to inform real-world medical practice and optimize patient outcomes by generating, and delivering clear, timely, and clinically relevant information that addresses the unmet medical needs of healthcare professionals, regulatory agencies, and other professional groups. Throughout the 2-year medical fellowship program, the fellow will have the opportunity to explore different functional areas within Medical, including: Scientific Communications, Medical Directors, and Real-World Evidence/Medical Research. The fellow will also pick one elective to prepare them for a career within the biopharmaceutical industry.
Global Regulatory Fellowship
The global regulatory (GRA) fellowship is designed to provide advanced, on-hands experience through rotational opportunities within the advertising, labeling and safety functions to develop a well-rounded industry professional in a GRA function. The fellow will rotate through Advertising and Promotion (AP), Labelling and Safety with elective options in either global medical and commercial. Our program is designed to enable fellows to build a strong skill set so that they can be prepared for a successful career in industry, no matter what it is.
Alkermes is in the process of partnering* with Northeastern University and the School of Pharmacy to offer a two-year Medical Affairs fellowship program starting in July 2018. Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
The company has a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Alkermes Medical Affairs strives to educate healthcare communities and decision makers on the value of our products through the generation and dissemination of scientifically rigorous, accurate, and unbiased clinical, economic, and health outcomes information, with the goal of advancing healthcare.
This new 2-year Doctor of Pharmacy Fellowship Program will support the Medical Affairs team at Alkermes located in Waltham, MA. During the fellowship program, the fellow will be able to work cross-functionally within Medical Affairs to gain a better understanding of the department while building upon key communication, leadership, project management, and problem solving skills. The fellow will start in the Medical Information department to gain knowledge and a comprehensive foundation on disease state, product and industry standards within Medical Affairs and will have the opportunity to rotate through various functions to play an integral part in a broad range of Medical Affairs activities.
For more information about the fellowship program, please contact us at firstname.lastname@example.org
TESARO is in the process of partnering* with Northeastern University and the School of Pharmacy to offer a two-year Medical Affairs fellowship program starting in July 2018. TESARO is a young, global biopharmaceutical company whose sole mission is to improve the lives of people bravely facing cancer. TESARO seeks new possibilities to responsibly develop and commercialize innovative treatments where others may not. Relationships are vital to the success of their business, and they are committed to being a trusted partner to the cancer community.
TESARO’s fellow will join a rapidly expanding company with multiple marketed products and a robust and diverse pipeline. TESARO’s development portfolio includes novel oncology and supportive care product candidates. Headquartered in Waltham, Massachusetts, TESARO currently operates in 7 countries worldwide, with plans to expand.
The Pharmacy Postdoctoral Fellow (Fellow) will join Global Medical Affairs for a two-year commitment, where they will be immersed in all US and Global Medical Affairs activities. Their first year will comprise primarily of rotations throughout Medical Affairs, where the Fellow will be expected to work on three-month long projects, which may be extended at the discretion of their rotation supervisor. After the first year, they will choose one area within Medical Affairs to conduct a dedicated three-month extended rotation. The remaining nine months will be fully dedicated to Medical Information activities. Throughout the fellowship, they will devote some of their time as a medical reviewer and will also present journal clubs and will participate in teaching and learning seminars (obtaining a certificate of achievement) at Northeastern University.
For more information about the fellowship program, please contact us at email@example.com
Under the direction of Dr. John Devlin, and in collaboration with Tufts Medical Center in Boston, the critical care fellowship at Northeastern University provides the ICU pharmacist with the skills to be able to answer pharmacotherapy-related questions posed in clinical practice through the design, implementation and and evaluation of methodologically-sound studies.